PDF(Pubmed)
Abstract：
BACKGROUND: Superficial femoral artery (SFA) pseudoaneurysms, a rare but potentially life-threatening complication, that can arise after vascular interventions or trauma. This case series explores the efficacy and safety of a minimally invasive treatment modality, percutaneous ultrasound-guided thrombin injection (PUGTI) combined with balloon occlusion, in three patients with SFA pseudoaneurysms.
METHODS: Three patients (age: 71-82 years; 3 female) with SFA pseudoaneurysms underwent PUGTI with balloon occlusion. The procedure involved direct thrombin injection under ultrasound guidance while occluding the parent artery using a balloon catheter. Follow-up was conducted at 1 week and 1 month post-procedure to assess technical success, complications, and recurrence.
CONCLUSIONS: PUGTI combined with balloon occlusion appears to be a safe and effective treatment for SFA pseudoaneurysms, particularly for larger pseudoaneurysms. The procedure is associated with a high technical success rate. Balloon occlusion may offer a safer alternative to direct thrombin injection without occlusion, as it potentially minimizes the risk of complications such as distal thromboembolism.
METHODS: Three patients (age: 71-82 years; 3 female) with SFA pseudoaneurysms underwent PUGTI with balloon occlusion. The procedure involved direct thrombin injection under ultrasound guidance while occluding the parent artery using a balloon catheter. Follow-up was conducted at 1 week and 1 month post-procedure to assess technical success, complications, and recurrence.
CONCLUSIONS: PUGTI combined with balloon occlusion appears to be a safe and effective treatment for SFA pseudoaneurysms, particularly for larger pseudoaneurysms. The procedure is associated with a high technical success rate. Balloon occlusion may offer a safer alternative to direct thrombin injection without occlusion, as it potentially minimizes the risk of complications such as distal thromboembolism.
摘要：
背景：股浅动脉（SFA）假性动脉瘤，一种罕见但可能危及生命的并发症，可能在血管介入或创伤后出现。本案例系列探讨了微创治疗方式的有效性和安全性，经皮超声引导凝血酶注射（PUGTI）联合球囊闭塞，在三例SFA假性动脉瘤患者中。
方法：3名SFA假性动脉瘤患者（年龄71-82岁；3名女性）接受PUGTI伴球囊闭塞。该程序包括在超声引导下直接注射凝血酶，同时使用球囊导管闭塞父动脉。在手术后1周和1个月进行随访，以评估技术成功。并发症,和复发。
结论：PUGTI联合球囊闭塞似乎是SFA假性动脉瘤安全有效的治疗方法，特别是对于较大的假性动脉瘤。该程序与较高的技术成功率相关联。球囊闭塞可以提供一个更安全的替代直接凝血酶注射没有闭塞，因为它有可能将远端血栓栓塞等并发症的风险降至最低。
方法：3名SFA假性动脉瘤患者（年龄71-82岁；3名女性）接受PUGTI伴球囊闭塞。该程序包括在超声引导下直接注射凝血酶，同时使用球囊导管闭塞父动脉。在手术后1周和1个月进行随访，以评估技术成功。并发症,和复发。
结论：PUGTI联合球囊闭塞似乎是SFA假性动脉瘤安全有效的治疗方法，特别是对于较大的假性动脉瘤。该程序与较高的技术成功率相关联。球囊闭塞可以提供一个更安全的替代直接凝血酶注射没有闭塞，因为它有可能将远端血栓栓塞等并发症的风险降至最低。
